The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
<p>Pneumococcal conjugate vaccines (PCVs) protect against invasive pneumococcal disease (IPD) among vaccinees. However, at population level, this protection is driven by indirect effects. PCVs prevent nasopharyngeal acquisition of vaccine-serotype (VT) pneumococci, reducing onward transmission...
Үндсэн зохиолчид: | Adamu, AL, Ojal, J, Abubakar, IA, Odeyemi, KA, Bello, MM, Okoromah, CAN, Karia, B, Karani, A, Akech, D, Inem, V, Scott, JAG, Adetifa, IMO |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Springer Nature
2023
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
-н: Aishatu L. Adamu, зэрэг
Хэвлэсэн: (2023-05-01) -
Nasopharyngeal pneumococcal carriage in Nigeria: A two-site, population-based survey
-н: Adetifa, I, зэрэг
Хэвлэсэн: (2018) -
Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study
-н: Hammitt, LL, зэрэг
Хэвлэсэн: (2019) -
Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey
-н: Ifedayo M. O. Adetifa, зэрэг
Хэвлэсэн: (2018-02-01) -
Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal population
-н: Deirdre A. Collins, зэрэг
Хэвлэсэн: (2017-09-01)